Literature DB >> 16102851

Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera.

A Zaki1, D Coudrier, A I Yousef, M Fakeeh, M Bouloy, A Billecocq.   

Abstract

This paper describes the production and characterization of RVFV monoclonal antibodies. The characteristics of 32 out of 55 ELISA and/or IFA positive monoclonal antibodies were determined, including the RVFV components against which they are directed. One monoclonal antibody recognized the nucleoprotein, 15 the Gc and 16 the Gn. Among the latter ones, five monoclonal antibodies possess another specificity and recognized both Gn and either the nucleoprotein (four of them) or the NSs protein (one). To validate the use of these monoclonal antibodies for diagnosis tests, a pool of monoclonal antibodies reacting with the structural proteins was prepared and used successfully to detect RVFV from cell culture as well as viral antigen-antibody complex in ELISA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102851     DOI: 10.1016/j.jviromet.2005.07.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  12 in total

1.  Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization.

Authors:  Raquel Martín-Folgar; Gema Lorenzo; Hani Boshra; Javier Iglesias; Francisco Mateos; Belén Borrego; Alejandro Brun
Journal:  MAbs       Date:  2010-05-02       Impact factor: 5.857

2.  Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.

Authors:  Nitin Bhardwaj; Mark T Heise; Ted M Ross
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

3.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

4.  Monoclonal antibody to dengue capsid protein: its application in dengue studies.

Authors:  Y Vazquez; Maritza Pupo-Antúnez; S V Vazquez; V Capó; G Torres; Y Caballero; A Sánchez; D Limonta; M Alvarez; M G Guzmán
Journal:  MAbs       Date:  2009-03-21       Impact factor: 5.857

Review 5.  Monitoring Symptoms of Infectious Diseases: Perspectives for Printed Wearable Sensors.

Authors:  Ala'aldeen Al-Halhouli; Ahmed Albagdady; Ja'far Alawadi; Mahmoud Abu Abeeleh
Journal:  Micromachines (Basel)       Date:  2021-05-27       Impact factor: 2.891

Review 6.  A highly pathogenic new bunyavirus emerged in China.

Authors:  Dexin Li
Journal:  Emerg Microbes Infect       Date:  2013-01-16       Impact factor: 7.163

Review 7.  Treatment alternatives of slaughterhouse wastes, and their effect on the inactivation of different pathogens: a review.

Authors:  Ingrid H Franke-Whittle; Heribert Insam
Journal:  Crit Rev Microbiol       Date:  2012-06-13       Impact factor: 7.624

8.  A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania.

Authors:  Calvin Sindato; Dirk U Pfeiffer; Esron D Karimuribo; Leonard E G Mboera; Mark M Rweyemamu; Janusz T Paweska
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

9.  Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen.

Authors:  Sandiswa Mbewana; Ann E Meyers; Brandon Weber; Vuyokazi Mareledwane; Maryke L Ferreira; Phelix A O Majiwa; Edward P Rybicki
Journal:  BMC Biotechnol       Date:  2018-12-11       Impact factor: 2.563

10.  Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes.

Authors:  Megumi Noda; Promsin Masrinoul; Chaweewan Punkum; Chonlatip Pipattanaboon; Pongrama Ramasoota; Chayanee Setthapramote; Tadahiro Sasaki; Mikiko Sasayama; Akifumi Yamashita; Takeshi Kurosu; Kazuyoshi Ikuta; Tamaki Okabayashi
Journal:  Biologics       Date:  2012-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.